Exiqon said this week that it has presented data showing its blood plasma-based microRNA PCR test for the early detection of colorectal cancer can achieve 82 percent sensitivity for detection of the cancer at 89 percent specificity.

Additional validation studies are expected to wrap up by year end, with data available for publication by the end of the first quarter of 2012. Exiqon added that it will begin a “large prospective validation study based on several thousands of individuals” early next year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.